VETERANS HEALTH ADMINISTRATION CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF COPD OR ASTHMA 
Outpatient Management of COPD: Insomnia (A8)

A. Consider Causes Other Than COPD for Insomnia - For classification of insomnia, refer to International Classification of Sleep Disorders. Polysomnography is rarely indicated.

Institute sleep hygiene measures (Zarcone 1994):

B. First Choice is Cautious Use of Zolpidem - If the decision is made to use a hypnotic, zolpidem is the first choice since it has generally been shown to be safe in multiple doses in COPD patients with FEV1 < 50 percent.

Hypnotics should be used after other measures have been implemented (see Annotation A) and used sparingly with close attention to the possibility of abuse and untoward side effects. If general measures and occasional hypnotics are unsuccessful, referral to a psychiatrist or sleep specialist is indicated. If used, hypnotics and sedatives may have an adverse effect in patients with FEV1 < 50 percent. Zolpidem has the most data indicating safety on multiple dose use in patients with FEV1 < 50 percent and should be first choice. Triazolam has no obvious effect on respiration when used in single doses in patients with SaO2 > 90 percent supine and may be considered a second choice to zolpidem in such patients. If patient has supine SaO2 < 90 percent, zolpidem is clearly the first choice; triazolam and other benzodiazepines must be used with extreme caution. If patient snores habitually, all hypnotics must be used with great caution as they may induce or exaggerate sleep apnea and hypopnea even in asymptomatic patients.

C. Follow-Up With Routine Care - Refer back to main algorithm as necessary. Refer to respiratory specialist if symptoms do not resolve as expected, if there are complications limiting therapy or if recommendations do not readily apply to client.

D. If SaO2 Supine is > 90 Percent, Use Benzodiazepines Cautiously - If decision is made to use hypnotic in COPD patients with FEV1 50 percent, benzodiazepines are first choice in patients with SaO2 90 percent. Otherwise zolpidem should be used.

As stated in Annotation B, except benzodiazepines hypnotics are not usually affected by presence of COPD of this degree unless there is supine SaO2 < 90 percent and can be used as first choice in patients with FEV1 > 50 percent. Zolpidem is first choice if SaO2 supine < 90 percent. 

TABLE OF EVIDENCE

Intervention References Grade of Evidence Strength of Recommendation
Hypnotic use of single and multiple doses of 10 mg zolpidem is safe and efficacious in stable COPD patients with FEV1 < 50 percent. Hypnotic use of single doses of 0.125 and 0.25 mg of triazolam is safe and efficacious in stable COPD patients with FEV1 < 50 percent and SaO2 > 90 percent. Triazolam reduces minute ventilation in such patients. Girault 1996 

Steens 1993 

Timms 1988 

Murciano 1993 


 
 

 
 
ASDA Practice Parameters for Indications for Polysomnography. ASDA 1997 B 1
ASDA nosology of sleep disorders  ASDA 1990 B 1
Sleep hygiene Zarcone 1994 C 1

Module A7 | Table of Contents | Module A9